Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.63 | 0.63 | 0.00 |
Stocks | 98.20 | 98.20 | 0.00 |
Convertible | 0.05 | 0.05 | 0.00 |
Preferred | 0.23 | 0.23 | 0.00 |
Other | 0.88 | 0.88 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.90 | 20.60 |
Price to Book | 4.65 | 4.61 |
Price to Sales | 2.13 | 2.52 |
Price to Cash Flow | 17.61 | 17.52 |
Dividend Yield | 1.18 | 1.10 |
5 Years Earnings Growth | 10.90 | 10.27 |
Number of long holdings: 120
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 6.63 | 770.09 | -0.13% | |
UnitedHealth | US91324P1021 | 5.96 | 524.65 | +0.65% | |
Novo Nordisk B | DK0062498333 | 4.81 | 903.3 | -1.05% | |
Merck&Co | US58933Y1055 | 3.56 | 131.20 | +0.24% | |
AstraZeneca | GB0009895292 | 3.56 | 12,110.0 | -0.46% | |
AbbVie | US00287Y1091 | 3.21 | 166.42 | +1.26% | |
Abbott Labs | US0028241000 | 2.49 | 104.11 | -0.72% | |
Sanofi | FR0000120578 | 2.46 | 89.17 | -1.19% | |
Vertex | US92532F1003 | 2.37 | 445.21 | +1.04% | |
Boston Scientific | US1011371077 | 2.29 | 74.66 | +0.15% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Research D | 15.17B | 10.08 | 7.33 | 13.53 | ||
Janus Balanced I | 10.64B | 3.21 | 3.28 | 8.16 | ||
Janus Henderson Balanced Portfolio | 8.06B | 3.16 | 3.08 | 7.88 | ||
Janus Enterprise I | 7.45B | 3.56 | 3.22 | 12.37 | ||
Janus Enterprise N | 6.11B | 3.59 | 3.32 | 12.47 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review